Andrew J Pierce, PhD

Bringing new medicines to cancer patients with science-led AI-enabled clinical development.

Connect on linkedin

Paralog Ltd provides scientific and strategic consulting services to life sciences companies, with a focus on biotech and oncology drug development. Services include clinical development strategy, programme oversight, biomarker strategy, scientific advisory input to boards and investors, and non-executive director roles. The company is directed by Dr Andrew J. Pierce, a senior drug development executive with over 20 years of experience across academic research, pharmaceutical companies, and biotechnology.